The prevalence of Alzheimer’s disease and related dementias (ADRD) is disproportionately high among rural, racially/ethnically diverse older residents. In fact, they face up to an 80% greater risk of cognitive impairment in older age, and 2.5 times potentially preventable ADRD-related hospitalizations compared to urban dwellers. It is estimated that early and accurate diagnosis in the mild cognitive impairment stage could save up to $7 trillion in patients’ health and long-term care costs by 2050.